Cervical cancer remains the second most common cancer among women worldwide, accounting for 15% of all female cancers (1) . The incidence of invasive cervical cancer varies considerably in different populations, reflecting the influence of variations in environmental factors, Pap smear surveillance, and the treatment of pre-invasive lesions. Although much is known about the contribution of oncogenic human papillomavirus (HPV) 1 to cervical dysplasia, only a small fraction of those infected eventually develop cancer, indicating that additional factors contribute to the progression to cervical cancer (2, 3) . The cellular pathophysiology of this disease remains largely unknown, and very little information is available on the roles of cellular ion transport systems in the neoplastic transformation and progression of cervical epithelial cells.
The KCl cotransporter family (KCC) plays a significant role in the ionic and osmotic homeostasis of many cell types. The cDNA products of four KCC genes have been cloned (4) . The activities of KCC1 and KCC4 are osmotically sensitive and involved in volume regulation (5, 6) . The neuron-specific KCC2 is critical for the maturation of inhibitory ␥-aminobutyric acid responses in the central nervous system by the control of intracellular Cl Ϫ concentration ([Cl Ϫ ] i ) (7) . KCC3, initially cloned from vascular endothelial cells (8) , may have a physiological significance in cell proliferation (9) .
We have demonstrated previously (10) that human cervical carcinogenesis is accompanied by increased expression of mRNA transcripts encoding KCC1, KCC3, and KCC4. However the lack of specific and potent pharmacological inhibitors of KCC (except [(dihydroindenyl)oxy] alkanoic acid (DIOA) at low concentrations) (11) has been a major obstacle to further studies on KCC function in human cervical carcinogenesis. More direct tests of the physiological functions of KCC and the consequences of loss of KCC activity require knock-out or knockdown experiments. Such experiments will involve either generation of homozygous knock-out animals or transgenic expression of dominant-negative or antisense constructs. Human cervical cancer cells express more than one KCC gene product. Thus, there is a serious possibility of functional compensation of the knock-out of one gene product by the unaltered or up-regulated expression of cognate genes.
Structure-function studies with KCC1 show that the removal of 117 amino acids from the N-terminal cytoplasmic domain of mouse KCC1 (⌬ N 117) confers a dominant-negative phenotype when coexpressed with gene products of human KCC1, KCC3, or mouse KCC4 (12) . Using the KCC1 dominant-negative mutants, the present study establishes KCl cotransport as an important modulator of growth and invasiveness of human cervical cancer.
MATERIALS AND METHODS
Surgical Specimens, Cell Cultures, Transfection, and Animal Models-Histopathological diagnosis was confirmed for 30 surgical specimens used in this study. Cultures of normal human cervical epithelial cells, HPV-immortalized Z183A and Z172 cell lines, and cervical cancer SiHa and HT-3 cell lines were prepared as described previously (10) . The dominant-negative mouse KCC ⌬ N 117 cDNA (12) was subcloned into the eukaryotic expression vector pCDNA3 (Invitrogen) and transfected into cervical cancer SiHa and HT-3 cells by lipofection, and stable lines were selected as described (9) . In the animal model, 5 ϫ 10 5 wild-type or ⌬ N 117 mutant cervical cancer cells were inoculated subcutaneously into female BALB/c SCID mice aged 6 -8 weeks (Jackson Immunoresearch Laboratories). The tumor xenografts were measured in two dimensions by caliper twice per week, starting one week after inoculation. Tumor volume was calculated by the following equation: width 2 ϫ length ϫ 1 ⁄2 (13). Tumor histology was examined 50 days after tumor transplantation.
Immunoblot and Immunofluorescence-Immunoblot analysis and immunofluorescence were performed in tumor tissues using affinitypurified antibodies against KCC1 N-terminal amino acids 1-14 or against KCC1 C-terminal amino acids 1074 -1085 (12, 14) or Na ϩ /K ϩ ATPase ␤1-subunit (Upstate Biotechnology, Inc.). For immunofluorescence, Alexa 488-labeled or Alexa 594-labeled secondary antibodies (Molecular Probes) and Hoechst 33258 (Sigma-Aldrich) were used. Sections were viewed with a laser-scanning confocal microscope (SPII; Leica). Electrophysiology, Cell Volume Measurement, and Na ϩ /K ϩ ATPase Enzymatic Activity-The whole-cell mode of the patch clamp technique was used to measure membrane currents at room temperature (22-25°C) as described previously (15) . To measure the activity of the swelling-activated Cl Ϫ channel, KCl was replaced by CsCl in media, and the pipette solutions contained the following (in mM): CsCl 40, Cs-aspartate 100, MgCl 2 1, CaCl 2 1.93, EGTA 5, ATP 2, GTP 0.5, and HEPES 5. Data from electrophysiological experiments were digitized and analyzed using pCLAMP software (Version 6.0.3; Axon Co., Foster City, CA). Cell volume was measured at room temperature as described previously (9, 15) , and data were presented as the ratio of starting volume (v/v 0 ) as a function of time. Na ϩ /K ϩ ATPase activity in cell homogenates was determined by ouabain-sensitive inorganic phosphate liberation from ATP. Protein concentration was measured by Lowry's assay (16 5 per dish on 60-mm dishes, and the medium was changed every 2 days. Counts were performed with the aid of a hemocytometer using trypan blue exclusion (0.08%) to monitor viability. After 3 days in culture, wild-type or ⌬ N 117 mutant cervical cancer cells were harvested on ice with protein sample buffer. Protein concentrations were determined by Lowry's protein assay. Immunoblots were first probed with phospho-specific antibodies against phospho-retinoblastoma (Rb) protein (Ser-795) and phospho-cdc2 (Tyr-15) (Cell Signaling Technology, Inc., Beverly, MA) and then stripped and reprobed with conventional antibodies to Rb and cdc2 kinase (Cell Signaling Technology, Inc.). Using the monoclonal antibodies (Chemicon, Temecula, CA) against integrins ␣ 6 , ␤ 4 , or ␣ v ␤ 3 , expression of integrin was determined by Western blot analysis as described in detail previously (18) .
Invasion Assay, Matrix Metalloproteinases (MMP) Zymography, and ELISA-Cell migration was assayed in the Boyden chamber as an index of invasive activity of the tumor cells. Matrigel was applied to the upper surface of the filter, and fibronectin was used as the chemoattractant in the lower compartment of the chamber (19) . Assays were run for 6 h in serum-free culture medium (Dulbecco's modified Eagle's medium) at 37°C. After incubation, cells were fixed with paraformaldehyde, stained with crystal violet, and counted immediately after staining. Conditioned medium from the invasion assays was cleared of cells and debris by centrifugation at 3000 ϫ g for 10 min. MMP-2 and MMP-9 activities were measured in the conditioned medium by gelatin zymography and by ELISA (Amersham Biosciences) as described previously (18) .
Statistics-All values in the present study were reported as mean Ϯ S.E. Student's paired or unpaired t test was used for statistical analyses. Differences between values were considered significantly when p Ͻ 0.05.
RESULTS

Overexpression of KCC in Human Cervical
Cancer-We first examined KCC polypeptide expression in surgical specimens of cervical cancer by immunofluorescent staining with antibody against the N-terminal of human KCC1 (capable of also detecting KCC4 (14)). KCC polypeptide was nearly undetectable in the normal cervical epithelial tissues ( ATPase (Fig. 1B) . The KCC immunofluorescence staining in cancer tissue was absent in the absence of primary antibody and was competed with peptide antigen but not irrelevant peptide.
One of the most significant functions of KCC is to facilitate cell volume regulation (20, 21) . As cell swelling is one of the major activating stimuli for KCl cotransport (5, 6), we investigated hypotonicity-stimulated KCC activity in various cervical epithelial cell lines representing different stages of cervical carcinogenesis (Fig. 2) . These included normal primary cervical epithelial cells, HPV-immortalized cells of low (Z172) and high tumor potential (Z183A), and cervical cancer cell lines (SiHa and HT-3). KCl cotransport in normal cervical epithelial cells and in Z172 cells was refractory to cell swelling but could be modestly activated by a hypotonic medium of 200 mosmol/liter. In contrast, KCl cotransport activity in cervical cancer cells (SiHa and HT-3) and in Z183A cells, though not different in isotonic medium, increased sharply as osmolarity was reduced. These results demonstrate a correlation between the osmotic sensitivity of KCl cotransport activity and different stages of cervical carcinogenesis.
Generation of Human Cervical Cancer Cell Lines with Reduced KCl
Cotransport Activity-We subsequently developed KCC mutant cervical cancer cell lines stably transfected with the dominant-negative ⌬ N 117 mutant KCC1 cDNA. Further experiments were performed to assess KCC regulation and confirm that ⌬ N 117 transfectants indeed exhibited reduced KCl cotransport. As shown in Fig. 3A , wild-type cervical cancer cells have KCC activity that is nearly quiescent in isotonic conditions. However high transport rates are observed in response to hypotonic challenge (230 mosmol/liter) and are inhibited by 20 M DIOA. In contrast, hypotonicity-stimulated KCC activity is completely abolished in ⌬ N 117 mutant cervical cancer cells. Treatment of wild-type cervical cancer cells with 1 M staurosporine led to a 10-fold stimulation of KCC activity. However, the KCC activity in ⌬ N 117 mutant cervical cancer cells is relatively insensitive to stimulation by staurosporine. Furthermore, whereas 0.5 mM N-ethylmaleimide (NEM) led to a 25-fold stimulation of KCC activity in wild-type cervical cancer cells, KCl cotransport in ⌬ N 117 mutant cervical cancer cells was only slightly increased (Fig. 3A) (Fig. 3) . Taken together, these functional assays indicate that ⌬ N 117 mutant cervical cancer cells exhibit dominant-negative suppression of KCl cotransport activity.
Role of KCl Cotransport in Cell Volume RegulationPrompted by the observation of substantially increased hypotonicity-stimulated KCl cotransport in cervical cancer cells, we tested the contribution of KCl cotransport activation to enhanced volume regulation of cervical cancer cells by comparison of regulatory volume decrease (RVD) in wild-type and ⌬ N 117 mutant cervical cancer cells. As shown in Fig. 4A , the typical volume response of wild-type cervical cancer cells to hypotonic medium (230 mosmol/liter) can be divided into three phases: (1) an initial, rapid osmotic swelling to reach a peak cell volume; (2) a subsequent, rapid shrinkage in the following 2-3 min; and (3) a later, more gradual decrease of cell volume to reach a plateau value after 10 -15 min. Addition of the KCC inhibitor DIOA (20 M), which should abolish hypotonicitystimulated KCl cotransport (Fig. 3A) , increased the initial, Remarkably, cervical cancer cells expressing the KCC1 ⌬ N 117 mutant exhibit a lower capacity for volume regulation than do wild-type cervical cancer cells treated with the KCC inhibitor, DIOA. The predominant pathway for RVD of human cervical cancer cells is the opening of the volume-sensitive organic osmolyte/anion channel (VSOAC), which leads to Cl Ϫ and taurine efflux (15) . Therefore, to further dissect the mechanisms of retarded RVD, the whole-cell mode of the patch clamp technique was used to measure membrane currents. As shown in Fig. 4 , B-E, the amplitude and activation rate of VSOAC were significantly decreased in ⌬ N 117 mutant cervical cancer cells. Consistently, in complementary taurine transport experiments, the swelling-activated taurine efflux rate constant decreased significantly from 0.06 Ϯ 0.002 min Ϫ1 (n ϭ 6) in wild-type cervical cancer cells to 0.032 Ϯ 0.001 min Ϫ1 (n ϭ 6) in ⌬ N 117 mutant cervical cancer cells (p Ͻ 0.01) (Fig. 4, F and  G) . These results indicate that reduced RVD in ⌬ N 117 mutant cells results from both the near abolition of hypotonicity-activated KCl cotransport and the down-regulation of VSOAC activity.
Suppression of Tumor Growth and Invasion by ⌬ N 117 Mutant-We have reported previously (9) that alteration of [Cl
Ϫ ] i can affect activities of Rb protein and cdc2 kinase, two key cell cycle regulators controlling progression through the restriction point from G 1 into S phase and from G 2 into M phase, respectively. Overexpression of the KCC1 mutant ⌬ N 117 elevates [Cl Ϫ ] i by decreasing the KCC activity (Fig. 3B) . We therefore hypothesized that the ⌬ N 117 KCC1 overexpression might alter cell proliferation. As shown in Rb protein and an increase in the phosphorylated inactive form of cdc2 kinase (Fig. 5B) , suggesting that KCC activity is important for the progression of the cell cycle clock.
The alteration of [Cl Ϫ ] i has been suggested as an important signal to regulate the activation of integrin in polymorphonuclear leukocytes (22, 23) . Although epithelial cells express a variety of cell adhesion molecules, integrins are the most important extracellular matrix receptors known to play a major role in the invasion and progression of most types of cancers (24) . Abnormal expression of integrins such as ␣ v ␤ 3 , ␣ 6 ␤ 4 , ␣ 2 ␤ 1 , and ␣ 3 ␤ 1 has been reported in human cervical cancer cells (25) (26) (27) . To study the role of integrins in tumor cell invasion, we assayed cell invasion in a Boyden chamber, as an in vitro model for cancer invasion in matrigel (19) . Function-blocking monoclonal antibodies against integrins ␣ v ␤ 3 , ␣ 6 , or ␤ 4 , but not ␣ 2 , ␣ 3 , or ␤ 1 , potently inhibited the invasion of wild-type cervical cancer SiHa cells, whereas IgG or boiled inactive monoclonal antibodies were without effect (Fig. 6A) . This indicates that ␣ v ␤ 3 and ␣ 6 ␤ 4 integrins might play an important role in the invasion of cervical cancer cells. Interestingly, the invasion of wild-type human cervical cancer cells was inhibited in a dose-dependent manner by KCC inhibitor, DIOA. Moreover, invasion is much attenuated in the ⌬ N 117 mutant cervical cancer cells (Fig. 6A) .
Conditioned medium collected from invasion assays was assessed for MMP activity. MMPs comprise a group of enzymes critically involved in the integrin-mediated dissolution of extracellular matrix (24, 28) . MMP-2 and MMP-9, highly expressed in wild-type cervical cancer cells, are released as a proenzyme (inactive form) that is proteolytically activated to the active form (Fig. 6B) . Compared with wild-type cells, ⌬ N 117 mutant cervical cancer cells showed decreased zymographic activity of MMP-2 (4-fold, p Ͻ 0.001) and MMP-9 (2-fold, p Ͻ 0.01). ELISA determinations confirmed the decreased activities of MMP-2 (4.5-fold, p Ͻ 0.001) and MMP-9 (2.6-fold, p Ͻ 0.01) in the ⌬ N 117 mutant cervical cancer cells (Fig. 6C) .
Because ␣ v ␤ 3 and ␣ 6 ␤ 4 integrins can play a critical role in cervical cancer invasion and cancer invasion is much attenuated in the ⌬ N 117 mutation (Fig. 6A) , the effect of altered KCC activity on the integrin expression of ␣ v ␤ 3 and ␣ 6 ␤ 4 was examined. Compared with wild-type cells, the ⌬ N 117 mutant cervical cancer cells demonstrated a significant decrease in expression of ␣ 6 ␤ 4 and ␣ v ␤ 3 integrins in Western blots (Fig. 7A) and in immunofluorescence analyses (Fig. 7B) . Taken together, the dominant- negative KCC phenotype is associated with inhibition of cell invasion accompanied by decreased the expression of ␣ 6 ␤ 4 and ␣ v ␤ 3 integrins and reduced MMP-2 and MMP-9 activities.
To avoid clonal variation and selection, we did the same series of functional assays in another four clones of cervical cancer SiHa and HT-3 cells stably transfected with the dominant-negative ⌬ N 117 mutant KCC1 cDNA. Similar results were obtained in the measurement of KCC activity, volume response, electrophysiology, proliferation, invasion ability, and integrin expressions (data not shown).
Tumor Growth and Invasion in SCID Mice-Down-regulation of cell proliferation and invasion suggests but does not prove an important role for KCl cotransport in the pathophysiology of human cervical cancer. To test whether manipulation of KCl cotransport alters tumor growth and invasion in vivo, we inoculated SCID mice subcutaneously with the wild-type or ⌬ N 117 mutant cervical cancer cell lines. Rapid tumor growth was obvious in the groups inoculated with wild-type cervical cancer cells (Fig. 8A) . The ⌬ N 117 mutation significantly reduced the rate of tumor growth and decreased the tumor size 50 days after grafting (Fig. 8, A and B) . The histology of SCID mice xenografts shows the malignant characteristics of wild-type cervical cancer cells, direct invasion into adjacent muscular tissues and blood vessels and formation of infiltrating nests of cells that vary greatly in size and contour (Fig. 8C) . The xenograft specimens resulting from inoculation of ⌬ N 117 mutant cells formed small tumors with intact capsules and without local invasion (Fig. 8D) . In addition, all xenografts resulting from inoculation of ⌬ N 117 mutant cells exhibit an area of central necrosis of varying size (Fig. 8D) . Moreover, the mitotic figures of wild-type cervical cancer cells are far more numerous than ⌬ N 117 mutant (80 Ϯ 3 versus 14 Ϯ 2 per high powered field (n ϭ 20), p Ͻ 0.001). Consistent with in vitro assay (Fig. 7,  A and B) , anti-integrin ␤ 4 and ␣ v ␤ 3 immunofluorescence analysis in xenograftic tumors resulting from the transplantation of ⌬ N 117 mutant cervical cancer cells showed reduced expression of integrins ␤ 4 and ␣ v ␤ 3 (Fig. 9A, green) . Immunoblots confirmed the presence of ⌬ N 117 KCC1 polypeptide in the small tumors (Fig. 9B) .
DISCUSSION
Electroneutral KCl cotransport has an important physiological function in cell volume regulation, transepithelial transport, and in the regulation of [Cl Ϫ ] i (20, 21) . In surgical specimens from cervical cancer patients, tumor cells express abundant KCC polypeptide, whereas KCC polypeptide expression is low in adjacent normal cervical tissues. This finding is consistent with our previous study (10) showing human cervical carcinogenesis is accompanied by the up-regulation of KCC mRNA. The main physiological function of KCC is to regulate cell volume, where KCC is activated by cell swelling (20, 21) . KCl cotransport in normal human cervical epithelial cells is quiescent in normal physiological conditions and of modest magnitude during hypotonic shock. KCl cotransport in cervical cancer cells is also nearly quiescent in the isotonic condition. However, hypotonicity activates in these cancer cells a high rate of KCl cotransport, which is critically involved in the RVD, a cellular defensive mechanism against osmotic shock. Cancer cells usually have higher rates of metabolism, mitosis, and migration than those of normal cells. Growth, mitosis, and migration can perturb cell volume homeostasis significantly. The maintenance of cell volume homeostasis is a fundamental property of mammalian cells, and most cells possess mechanisms to regulate their volume during osmotic challenge. The close linkage of cell volume regulation and cell proliferation implies that the overexpression of KCl cotransport activity may be a selective advantage for cervical cancer cells.
Here we provide evidence to support the hypothesis that KCC activity is critical for proliferation and invasion of cervical cancer cells and possibly also for tumorigenesis. The functional assays of KCl cotransport activation by osmotic swelling, staurosporine, and NEM indicate that, as in Xenopus oocytes (12), removal of the N-terminal 117 amino acids from KCC1 produces a dominant-negative loss-of-function phenotype for KCl cotransport in human cervical cancer cells. Overexpression of the N-terminal truncation mutant offers a unique genetic tool for functional inhibition of all KCC gene products in cervical cancer cells. Inactivation of KCl cotransport by either inhibitor (DIOA) or by the dominant-negative ⌬ N 117 mutant profoundly suppressed the invasive ability of cervical cancer cells.
We considered two possible explanations for the potent antitumor effect of overexpression of KCC1 ⌬ N 117. First, and most simply, the ⌬ N 117 mutant changes the regulatory mechanisms of cell volume control. Cancer invasion is a complex process of cell adhesion, migration, and secretion of different classes of enzymes (24, 28) . Cell migration involves substantial alterations of cell volume, and thus volume regulatory mechanisms are certainly activated (29) . The present and previous studies (10, 15) mutation abolishes hypotonicity-induced KCl cotransport and down-regulates VSOAC, thereby retarding RVD. Cellular invasiveness is therefore affected by overexpression of ⌬ N 117 mutant.
Second, and perhaps more importantly, KCC activity appears to be associated with MMP activation and integrin expression. In carcinogenesis, cervical epithelial cells breach the basement membrane to proliferate and migrate within the adjacent connective tissue. An important event in the dissolution of the matrix of the basement membrane involves the activation of MMP cascade, which is accompanied by altered expression of several cell adhesion molecules by the transformed cells (24, 28 ). Here we demonstrate that the function of ␣ v ␤ 3 and ␣ 6 ␤ 4 integrins in the invasion of cervical cancer cells. Pharmacological inhibition and genetic modification studies both indicate that KCC activity parallels the invasive ability of cervical cancer cells. Gel activity assays, immunoblots, and immunofluorescent staining further suggest that the dominant-negative KCC phenotype is associated with the decreased expression of ␣ v ␤ 3 and ␣ 6 ␤ 4 integrins, which is accompanied, in turn, by inactivation of MMP-2 and MMP-9.
These findings suggest a novel function of KCl cotransport in cancer invasion, the regulation of integrin expression and of MMP activity. The role of [Cl Ϫ ] i has been suggested as an important second messenger to regulate ␤ 2 integrin activation of polymorphonuclear leukocytes in response to tumor necrotic factor stimulation (22, 23) . Further work will be required to determine whether these changes in integrin and MMP expression reflect KCC-associated changes in [Cl Ϫ ] i or [K ϩ ] i or other functions of KCC possibly unrelated to ion transport. Such transport-independent cytoskeletal and signaling functions have been described for the Na ϩ /H ϩ exchanger NHE1 in cultured fibroblasts (30) .
It is interesting to find that ⌬ N 117 mutant cervical cancer cells exhibit little capacity for RVD, secondary to inhibition of KCl cotransport and down-regulation of VSOAC activity. This suggests an interaction at either the signaling or membrane activity levels of the RVD process. We have demonstrated previously (31) that the activity of VSOAC is differentially expressed during the cell cycle progression of human cervical cancer cells. To block this channel activity could inhibit cell proliferation by arresting the cell cycle progression. Thus, the down-regulation of the VSOAC activity by KCC mutation would have a profound impact on cell proliferation. However, until the molecular identities of VSOAC are established, we are limited to indirect methods to show this unusual function of KCC mutation on the ion channel activity. Nevertheless, the use of dominant-negative mutants allows us to make some significant progress in demonstrating the novel role of KCl cotransport in cell volume regulation.
In conclusion, the above results indicate that KCl cotransport plays a crucial role in the growth and invasion of human cervical cancer. Blockade of KCl cotransport may be a useful therapeutic adjunctive strategy to retard or prevent cervical cancer invasion.
